Stakeholders Expect Obama's Precision Medicine Effort To Complement Cures Initiative

January 21, 2015 at 8:09 PM
President Barack Obama's newly announced Precision Medicine Initiative would double funding for antibiotic development while continuing investment in Alzheimer's and brain research, and while the details remain scant the personalized medicine initiative is viewed by key stakeholders as complementary to the House Energy and Commerce panel's emerging 21st Century Cures Initiative. One stakeholder says the initiative may have roots in a bipartisan bill that Obama sponsored while senator. Obama described the initiative during his State of the Union Address Tuesday...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.